Christina Takke, Managing Partner | V-Bio Ventures
She holds a PhD in Developmental Biology, which she obtained at the Institute of Development Biology of the University of Cologne. Christina currently serves on the board of V-Bio’s portfolio companies Confo Therapeutics NV, Octimet NV, Oxular Ltd, Precirix NV and Syndesi SA. In recent years she served among others on the board of argenx NV.
V-Bio Ventures is a life sciences Venture Capital fund that helps transform scientific innovation into products that positively impact people’s lives. We invest in private companies with differentiated technology addressing unmet needs. We look for innovative and transformational technologies with high societal and/or environmental impact potential, in line with the U.N. Sustainable Development Goals.We focus on therapeutics, diagnostics supporting medical therapies, and sustainable agriculture.
Read more
Powered by: Hyphen Projects | Let's connect: |
Book a ticket
| |||
FAQ Contact Us Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
|
Keep me informed
Download our event app
|
© Copyright 2025 by Hyphen Projects